ISBN: 9781009016933 - personalized drug screening for functional tumor profiling (elements in molecular oncology) (12 Ergebnisse)

paperback. Zustand: Very Good. Cover and edges may have some wear.

Zustand: New.

Zustand: New.

Paperback. Zustand: Brand New. 75 pages. 8.90x5.98x0.28 inches. In Stock.

Zustand: New.

Taschenbuch. Zustand: Neu. Neuware - Despite considerable advances in our understanding of the biology that underlies tumor development and progression of cancer and the rapidly evolving field of personalized medicine, cancer is still one of the deadliest diseases. Many cancer patients have benefited from the survival improvements observed with targeted therapies but only a small subset of patients receiving targeted drugs experience an objective response. Because cancer is a complex and heterogeneous disease, the search for effective cancer treatments will need to address not only patient-specific molecular defects but also aspects of the tumor microenvironment. The functional tumor profiling directly measures the cellular phenotype, in particular tumor growth, in response to drugs using patient-derived tumor models and might be the next step toward precision oncology. In this Element, the authors discuss the personalized drug screening as a novel patient stratification strategy for the determination of individualized treatment choices in oncology.…

Zustand: New. This Element discusses personalized drug screening as a novel patient stratification strategy for the determination of individualized treatment choices in oncology.Inhaltsverzeichnis1. Rationale for functional profiling in oncology .

Zustand: New. Print on Demand.

Zustand: New. Print on Demand New edition NO-PA16APR2015-KAP.

Zustand: New. PRINT ON DEMAND.

Paperback / softback. Zustand: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Paperback. Zustand: new. Paperback. Despite considerable advances in our understanding of the biology that underlies tumor development and progression of cancer and the rapidly evolving field of personalized medicine, cancer is still one of the deadliest diseases. Many cancer patients have benefited from the survival improvements observed with targeted therapies but only a small subset of patients receiving targeted drugs experience an objective response. Because cancer is a complex and heterogeneous disease, the search for effective cancer treatments will need to address not only patient-specific molecular defects but also aspects of the tumor microenvironment. The functional tumor profiling directly measures the cellular phenotype, in particular tumor growth, in response to drugs using patient-derived tumor models and might be the next step toward precision oncology. In this Element, the authors discuss the personalized drug screening as a novel patient stratification strategy for the determination of individualized treatment choices in oncology. This Element discusses personalized drug screening as a novel patient stratification strategy for the determination of individualized treatment choices in oncology. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…